Table 1. Baseline characteristics of CHD patients and HS.
| Variables | CHD (n = 65) |
HS (n = 30) |
p value |
|---|---|---|---|
| Age (years)* | 63.12 ± 11.0 | 57.87 ± 9.60 | 0.016 |
| Men (%) | 49 (75.4%) | 13 (43.3%) | 0.002 |
| BMI (kg/m2)* | 27.86 ± 4.52 | 27.40 ± 3.92 | 0.728 |
| HR (bpm) | 64.45 ± 12.39 | 69.70 ± 17.12 | 0.152 |
| LVEF (%) | 68.30 ± 9.34 | 68.21 ± 11.04 | 0.974 |
| Pericardial fat (mL)* | 175.33 ± 90.2 | 150.90 ± 74.00 | 0.327 |
| CHD familiarity (%) | 39 (60%) | 17 (56.7%) | 0.759 |
| Smoke (%) | 20 (30.8%) | 8 (26.7%) | 0.684 |
| Hypertension (%) | 43 (66.2%) | 22 (73.3%) | 0.484 |
| Diabetes (%) | 9 (13.8) | 1 (3.3%) | 0.163 |
| Dyslipidemia (%) | 37 (56.9%) | 12 (40%) | 0.125 |
| Total cholesterol (mg/dL)* | 186.4 ± 46.4 | 189.3 ± 38.7 | 0.721 |
| LDL cholesterol (mg/dL)* | 103.8 ± 36.4 | 117.3 ± 31.5 | 0.103 |
| HDL cholesterol (mg/dL)* | 53.0 ±18.6 | 50.3 ± 10.6 | 0.372 |
| Physical activity (%) | 27 (41.5%) | 5 (16.7%) | 0.020 |
| Anti-hypertensive therapy (%) | 39 (60%) | 18 (60%) | 1.000 |
| Dyslipidemia treatment (%) | 29 (44.6%) | 5 (16.7%) | 0.007 |
*Data are represented as mean ± SD. Bold values were considered statistically significant with a p < 0.05.
CHD, coronary artery disease; BMI, body mass index; HDL, high density lipoprotein; HR, heart rate; HS, healthy subjects; LVEF, left ventricular ejection fraction; LDL, low density lipoprotein